Activity maintained for recombinant factor VIII modified to extend half-life: MG-1121 July 16, 2019 No Comments
Bodyweight-adjusted rivaroxaban treatment in children with acute venous thromboembolism July 15, 2019 No Comments
New CRISPR/Cas9 transgenic mice with mutated F8 gene as a model for the study of hemophilia A July 15, 2019 No Comments
BioCryst opens enrollment in phase I study of oral factor D inhibitor BCX-9930 June 28, 2019 No Comments
EC grants marketing authorization for Doptelet for severe thrombocytopenia in adults with CLD June 26, 2019 No Comments
European Commission approves Esperoct for adolescents and adults with hemophilia A June 21, 2019 No Comments
RSS